跳至主要内容
临床试验/NCT03603496
NCT03603496已完成4 期

Comparative Effectiveness of Post-Discharge Strategies for Hospitalized Smokers

Massachusetts General Hospital3 个研究点 分布在 1 个国家目标入组 1,416 人开始时间: 2018年9月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
1,416
试验地点
3
主要终点
Tobacco Abstinence, Biochemically Confirmed

研究概览

简要总结

This randomized controlled trial will compare the effectiveness of two models of post-discharge tobacco cessation treatment for adult smokers admitted to 3 U.S. hospitals.

详细描述

This multi-site randomized controlled trial (RCT) will compare the effectiveness of two models of post-discharge tobacco cessation treatment for adult smokers who are admitted to 3 large hospital systems in 3 U.S. regions (MA, PA, TN). All patients will receive guideline-based tobacco cessation treatment delivered in hospital by each site's existing Tobacco Treatment Service that is directed by a study investigator. Patients who plan to quit smoking after hospital discharge will be randomly assigned to 1 of 2 post-discharge tobacco treatment interventions and followed at 1, 3, and 6 months. One arm uses bidirectional electronic referral (eReferral) to the state tobacco quitline. The other arm, Personalized Tobacco Care Management (PTCM), combines proactive messages delivered by automated interactive voice response (IVR) phone calls, text messaging, and/or email with health coaching provided by a hospital-based tobacco counselor. Both groups will receive at least 1 month of nicotine replacement therapy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18 years of age or older
  • Current cigarette smoker (>=1 cigarette in the week before admission and >=1 cigarette/day when smoking at a baseline rate in the month prior to admission)
  • Admitted to a study hospital
  • Seen by hospital smoking counselor during inpatient stay
  • Plans to try to quit smoking after hospital discharge

排除标准

  • Inability to give informed consent or participate in counseling due to serious cognitive or psychiatric disorder (e.g., dementia, psychosis)
  • Life expectancy <12 months
  • Medical instability
  • No reliable telephone access or inability to use telephone
  • Non-English speaking
  • Pregnant, breastfeeding, to planning to become pregnant in the next 6 months.

研究组 & 干预措施

Transitional Tobacco Care Management (TTCM)

Experimental

TTCM will provide 8 weeks of nicotine replacement therapy at hospital discharge and proactive contacts over 3 months delivered by automated IVR call. At each contact the patient is offered a return call from the hospital-based tobacco coach for counseling, medication advice, and coordination of care with the patient's outpatient health care team.

干预措施: Transitional Tobacco Care Management (TTCM) (Behavioral)

Transitional Tobacco Care Management (TTCM)

Experimental

TTCM will provide 8 weeks of nicotine replacement therapy at hospital discharge and proactive contacts over 3 months delivered by automated IVR call. At each contact the patient is offered a return call from the hospital-based tobacco coach for counseling, medication advice, and coordination of care with the patient's outpatient health care team.

干预措施: Nicotine replacement therapy (Drug)

eReferral to State Tobacco Quitline (QL)

Active Comparator

Referral from hospital to the state Quitline will be made by the research team on behalf of each enrolled patient. Quitline staff will contact patient to offer up to 5 proactive telephone calls from a tobacco coach. Patient may also be eligible for NRT sample. Feedback from the quitline will be sent back to the patient's medical chart.

干预措施: eReferral to State Tobacco Quitline (QL) (Behavioral)

eReferral to State Tobacco Quitline (QL)

Active Comparator

Referral from hospital to the state Quitline will be made by the research team on behalf of each enrolled patient. Quitline staff will contact patient to offer up to 5 proactive telephone calls from a tobacco coach. Patient may also be eligible for NRT sample. Feedback from the quitline will be sent back to the patient's medical chart.

干预措施: Nicotine replacement therapy (Drug)

结局指标

主要结局

Tobacco Abstinence, Biochemically Confirmed

时间窗: 6 months after hospital discharge

Participant self-report of no use of any tobacco product (cigarettes, cigars, little cigars, pipes, smokeless tobacco product) in the past 7 days AND either a saliva sample with a cotinine concentration \<=10 ng/ml OR breath sample with a carbon monoxide concentration \<=9 ppm.

次要结局

  • Tobacco Abstinence, Self-report(6 months after hospital discharge)
  • Engagement in Cessation Treatment(3 months after hospital discharge)
  • Self-reported Continuous Tobacco Abstinence Since Hospital Discharge(6 months follow-up)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Nancy A. Rigotti

Professor of Medicine

Massachusetts General Hospital

研究点 (3)

Loading locations...

相似试验

Post-Discharge Smoking Cessation Strategies: Helping... | 临床试验